(Q41504780)

1 October 2017

1 reference

title

The role of erythropoietin in the anemia of prematurity (English)

1 reference

1 October 2017

1 reference

Doyle JJ

1

1 reference

1 October 2017

publication date

1 February 1997

1 reference

1 October 2017

published in

Seminars in Perinatology

1 reference

1 October 2017

volume

21

1 reference

1 October 2017

issue

1

1 reference

1 October 2017

page(s)

20-27

1 reference

Effect of blood transfusion on cardiorespiratory abnormalities in preterm infants

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

The anemia of prematurity. Factors governing the erythropoietin response

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Plasma erythropoietin concentrations during the early anemia of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with the "anemia of prematurity"

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Circulating erythroid progenitors in the anemia of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Erythropoietin responsive progenitors in anaemia of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Erythropoietin production by macrophages from preterm infants: implications regarding the cause of the anemia of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Decreased response of plasma immunoreactive erythropoietin to "available oxygen" in anemia of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Anemia of prematurity: determinants of the erythropoietin response

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Case study. Erythropoietin for anaemia in a preterm Jehovah's Witness baby

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Erythropoietin in very preterm infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Avoidance of red blood cell transfusion in an extremely preterm infant given recombinant human erythropoietin therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Weekly intravenous administration of recombinant human erythropoietin in infants with the anaemia of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Effects of recombinant human erythropoietin in infants with the anemia of prematurity: A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Recombinant human erythropoietin in the treatment of infants with anaemia of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Efficacy and safety of recombinant human erythropoietin to prevent the anaemias of prematurity. European Randomized Multicenter Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Erythropoietin, protein, and iron supplementation and the prevention of anaemia of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Effects of recombinant human erythropoietin on fetal and adult hemoglobin in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Erythropoietin (Epo), protein and iron supplementation and the prevention of anaemia of prematurity: effects on serum immunoreactive Epo, growth and protein and iron metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Double blind trial of recombinant human erythropoietin in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

In which neonates does early recombinant human erythropoietin treatment prevent anemia of prematurity? Results of a randomized, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Recombinant human erythropoietin in the treatment of anemia of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Decreased ferritin levels, despite iron supplementation, during erythropoietin therapy in anaemia of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Prediction of the need for transfusion during anemia of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Prospective, randomized trial of the safety and efficacy of a limited donor exposure transfusion program for premature neonates.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Reducing blood donor exposures in low birth weight infants by the use of older, unwashed packed red blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

A randomized, double-blind, placebo-controlled trial of recombinant erythropoietin in treatment of the anemia of bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Effect of recombinant human erythropoietin on the switchover from fetal to adult hemoglobin synthesis in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Suppression of erythropoiesis by intrauterine transfusions in hemolytic disease of the newborn: Use of erythropoietein to treat the late anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Recombinant human erythropoietin: possible role as an antioxidant in premature rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

Erythropoietin receptors are expressed in the central nervous system of mid-trimester human fetuses.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2897%2980016-X

7 January 2021

10.1016/S0146-0005(97)80016-X

Identifiers

DOI

1 reference

1 October 2017

1 reference